X-17375851-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001291867.2(NHS):āc.94G>Cā(p.Ala32Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000177 in 1,129,870 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001291867.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.94G>C | p.Ala32Pro | missense_variant | 1/9 | ENST00000676302.1 | |
NHS | NM_198270.4 | c.94G>C | p.Ala32Pro | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.94G>C | p.Ala32Pro | missense_variant | 1/9 | NM_001291867.2 | P4 | ||
NHS | ENST00000380060.7 | c.94G>C | p.Ala32Pro | missense_variant | 1/8 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112198Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34478
GnomAD4 exome AF: 9.83e-7 AC: 1AN: 1017672Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 328076
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112198Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34478
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.94G>C (p.A32P) alteration is located in exon 1 (coding exon 1) of the NHS gene. This alteration results from a G to C substitution at nucleotide position 94, causing the alanine (A) at amino acid position 32 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at